Jared Fischer, Ph.D., and Jose Luis Montoya Mira, Ph.D., cancer researchers at Oregon Health & Science University, have developed PAC-MANN, a test that uses a small blood sample to detect changes in protease activity, a key indicator of pancreatic ductal adenocarcinoma (PDAC), the most common and deadliest form of pancreatic cancer. (OHSU/Christine Torres Hicks)
New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers. Researchers at Oregon Health & Science University have developed…